TTCI Representative Delivers Award-Winning Oral Presentation at JACI 2026 in Japan
- October 15, 2026
- admin@narisara
- 0
TTCI Researcher Wins Excellent Presentation Award at JACI 2026 in Japan
October 15, 2026
TAKAMATSU, JAPAN – The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) proudly congratulates Dr. Wannakorn Khopanlert, representing TTCI and the Center of Excellence in Stem Cell Transplantation and Cellular Therapy, Faculty of Medicine, Prince of Songkla University (PSU), on receiving the prestigious "Excellent Presentation Award for General Topics" at The 30th Annual Meeting of the Japanese Association of Cancer Immunology (JACI 2026), held on July 22–24, 2026, in Takamatsu, Japan.
Recognizing Excellence in Academic CAR-T Cell Therapy Research
Working in collaboration with Assoc. Prof. Dr. Jakrawadee Julamanee and the research team at Prince of Songkla University, Dr. Wannakorn delivered an award-winning oral presentation entitled:
"Academic PSU CAR-T: Favorable Safety, Long-Term Persistence and Durable Remissions in Heavily Pretreated Patients with Relapsed/Refractory B-Cell Malignancies"
The presentation highlighted the team's research on academic CAR-T cell therapy, focusing on its favorable safety profile, long-term cellular persistence, and durable clinical remissions in heavily pretreated patients with relapsed or refractory B-cell malignancies.
Showcasing Thai Research Excellence on the International Stage
The recognition at JACI 2026 underscores the growing contributions of Thai researchers to the international cancer immunotherapy community and reflects the dedication of the PSU research team to advancing innovative cellular therapies.
This achievement also highlights the importance of collaborative research networks in strengthening Thailand's capacity for academic CAR-T cell development and clinical translation.
Congratulations to the Award-Winning Research Team
TTCI extends its warmest congratulations to Dr. Wannakorn Khopanlert, Assoc. Prof. Dr. Jakrawadee Julamanee, and the entire PSU research team on this outstanding achievement.
This prestigious recognition reflects the scientific excellence, dedication, and growing international impact of Thai researchers in advancing cancer immunotherapy and improving future treatment opportunities for patients.
Together, we continue to advance cancer immunotherapy research and strengthen Thailand's presence in the global scientific community.
Official Website: www.ttci-th.org
Recognizing Excellence in Academic CAR-T Cell Therapy Research
Working in collaboration with Assoc. Prof. Dr. Jakrawadee Julamanee and the research team at Prince of Songkla University, Dr. Wannakorn delivered an award-winning oral presentation entitled:
"Academic PSU CAR-T: Favorable Safety, Long-Term Persistence and Durable Remissions in Heavily Pretreated Patients with Relapsed/Refractory B-Cell Malignancies"
The presentation highlighted the team's research on academic CAR-T cell therapy, focusing on its favorable safety profile, long-term cellular persistence, and durable clinical remissions in heavily pretreated patients with relapsed or refractory B-cell malignancies.
Showcasing Thai Research Excellence on the International Stage
The recognition at JACI 2026 underscores the growing contributions of Thai researchers to the international cancer immunotherapy community and reflects the dedication of the PSU research team to advancing innovative cellular therapies.
This achievement also highlights the importance of collaborative research networks in strengthening Thailand's capacity for academic CAR-T cell development and clinical translation.
Congratulations to the Award-Winning Research Team
TTCI extends its warmest congratulations to Dr. Wannakorn Khopanlert, Assoc. Prof. Dr. Jakrawadee Julamanee, and the entire PSU research team on this outstanding achievement.
This prestigious recognition reflects the scientific excellence, dedication, and growing international impact of Thai researchers in advancing cancer immunotherapy and improving future treatment opportunities for patients.
Together, we continue to advance cancer immunotherapy research and strengthen Thailand's presence in the global scientific community.
Official Website: www.ttci-th.org
Tags: Chulalongkorn University



